Literature DB >> 17045821

CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex.

Xuerong Shi1, Lin Leng, Tian Wang, Wenkui Wang, Xin Du, Ji Li, Courtney McDonald, Zun Chen, James W Murphy, Elias Lolis, Paul Noble, Warren Knudson, Richard Bucala.   

Abstract

The macrophage migration inhibitory factor (MIF) receptor (CD74) was cloned recently, but the signaling mechanism is not evident. We hypothesized that signaling requires an additional molecule such as CD44, which activates nonreceptor tyrosine kinases. We utilized the CD74- and CD44-deficient COS-7/M6 cell to create stable transfectants expressing CD74, CD44, and a truncated CD44 lacking its intracytoplasmic signaling domain. CD74 alone mediated MIF binding; however, MIF-induced ERK1 and ERK2 kinase phosphorylation required the coexpression of full-length CD44. MIF binding was associated with the serine phosphorylation of CD74 and CD44. Investigations that used siRNA or kinase inhibitors indicate that MIF-induced ERK1 and ERK2 activation through CD44 required the Src tyrosine kinase. Studies of CD74, CD44, and CD74-CD44 transformants and corresponding mutant cells showed that CD74 and CD44 were necessary for MIF protection from apoptosis. These data establish CD44 as an integral member of the CD74 receptor complex leading to MIF signal transduction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17045821      PMCID: PMC3707630          DOI: 10.1016/j.immuni.2006.08.020

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  62 in total

1.  Role for macrophage migration inhibitory factor in asthma.

Authors:  Y Mizue; S Ghani; L Leng; C McDonald; P Kong; J Baugh; S J Lane; J Craft; J Nishihira; S C Donnelly; Z Zhu; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

2.  Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells.

Authors:  E P Salazar; E Rozengurt
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

3.  Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action.

Authors:  R A Mitchell; C N Metz; T Peng; R Bucala
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

4.  Rho GTPase-dependent signaling is required for macrophage migration inhibitory factor-mediated expression of cyclin D1.

Authors:  James D Swant; Beatriz E Rendon; Marc Symons; Robert A Mitchell
Journal:  J Biol Chem       Date:  2005-04-19       Impact factor: 5.157

5.  Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.

Authors:  Hongqi Lue; Aphrodite Kapurniotu; Günter Fingerle-Rowson; Thierry Roger; Lin Leng; Michael Thiele; Thierry Calandra; Richard Bucala; Jürgen Bernhagen
Journal:  Cell Signal       Date:  2005-08-24       Impact factor: 4.315

6.  Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB.

Authors:  M Asif Amin; Christian S Haas; Kui Zhu; Pamela J Mansfield; Michael J Kim; Nicholas P Lackowski; Alisa E Koch
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

7.  Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival.

Authors:  Diana Starlets; Yael Gore; Inbal Binsky; Michal Haran; Nurit Harpaz; Lev Shvidel; Shirly Becker-Herman; Alain Berrebi; Idit Shachar
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

8.  SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.

Authors:  Addolorata Maria Luce Coluccia; Daniela Benati; Hafedh Dekhil; Annamaria De Filippo; Cathy Lan; Carlo Gambacorti-Passerini
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

9.  Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis.

Authors:  M Bozza; A R Satoskar; G Lin; B Lu; A A Humbles; C Gerard; J R David
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

10.  A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.

Authors:  Michael A McDevitt; Jianlin Xie; Shanmugasundaram Ganapathy-Kanniappan; Ganapathy Shanmugasundaram; Jason Griffith; Aihua Liu; Courtney McDonald; Philip Thuma; Victor R Gordeuk; Christine N Metz; Robert Mitchell; Jeffrey Keefer; John David; Lin Leng; Richard Bucala
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

View more
  244 in total

1.  Macrophage migration inhibitory factor deficiency augments cardiac dysfunction in Type 1 diabetic murine cardiomyocytes.

Authors:  Chao Tong; Alex Morrison; Xiaoyan Yan; Peng Zhao; Eddie D Yeung; Jingying Wang; Jianxin Xie; Ji Li
Journal:  J Diabetes       Date:  2010-12       Impact factor: 4.006

2.  The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74.

Authors:  Sivan Cohen; Or-yam Shoshana; Einat Zelman-Toister; Nitsan Maharshak; Inbal Binsky-Ehrenreich; Maya Gordin; Inbal Hazan-Halevy; Yair Herishanu; Lev Shvidel; Michal Haran; Lin Leng; Richard Bucala; Sheila Harroch; Idit Shachar
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

3.  Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.

Authors:  Yoonsang Cho; Gregg V Crichlow; Jon J Vermeire; Lin Leng; Xin Du; Michael E Hodsdon; Richard Bucala; Michael Cappello; Matt Gross; Federico Gaeta; Kirk Johnson; Elias J Lolis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-08       Impact factor: 11.205

Review 4.  D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.

Authors:  Melanie Merk; Robert A Mitchell; Stefan Endres; Richard Bucala
Journal:  Cytokine       Date:  2012-04-14       Impact factor: 3.861

Review 5.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

6.  Ostertagia ostertagi macrophage migration inhibitory factor is present in all developmental stages and may cross-regulate host functions through interaction with the host receptor.

Authors:  Guanggang Qu; Raymond Fetterer; Lin Leng; Xin Du; Dante Zarlenga; Zhiqiang Shen; Wenyu Han; Richard Bucala; Wenbin Tuo
Journal:  Int J Parasitol       Date:  2014-02-28       Impact factor: 3.981

7.  Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74.

Authors:  Roberto Meza-Romero; Gil Benedek; Kelley Jordan; Lin Leng; Georgios Pantouris; Elias Lolis; Richard Bucala; Arthur A Vandenbark
Journal:  Cytokine       Date:  2016-08-27       Impact factor: 3.861

Review 8.  The biological function and significance of CD74 in immune diseases.

Authors:  Huiting Su; Ning Na; Xiaodong Zhang; Yong Zhao
Journal:  Inflamm Res       Date:  2016-10-17       Impact factor: 4.575

Review 9.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

10.  Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets.

Authors:  Nadège Kindt; Fabrice Journe; Guy Laurent; Sven Saussez
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.